Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Dipeptidyl Peptidase-IV (DPP-IV) is a serine exopeptidase enzyme that cleaves N-terminal dipeptides from peptides, particularly those with proline or alanine at the penultimate position. This action inactivates incretins like GLP-1 and GIP, and also facilitates the breakdown of dietary proteins like gluten and casein.
Reported Benefits (Provisional)
Origin & History
Dipeptidyl Peptidase-IV (DPP-IV) is a specialized proteolytic enzyme that breaks down proline-containing peptides, such as gluten and casein, into smaller, more digestible fragments. Found in the human body and certain microbial sources, it is commonly used in digestive health supplements. DPP-IV helps individuals with gluten or casein sensitivities by reducing the adverse effects of these proteins on digestion and overall wellness.
Research Narrative (Provisional)
DPP-IV enzyme has been researched for its efficacy in breaking down proline-rich peptides, particularly gluten and casein. Studies support its use in managing symptoms associated with dietary protein sensitivities and improving digestive comfort.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Proline-Specific Activity: Targets and breaks down proline-rich peptides like gluten and casein. - Digestive Aid: Enhances protein digestion for improved nutrient absorption. - Anti-Inflammatory Properties: Reduces gut irritation and immune responses linked to protein sensitivities.
Reported Mechanism (Provisional)
DPP-IV is a serine exopeptidase enzyme that acts by hydrolyzing N-terminal dipeptides from peptides, specifically targeting those with proline or alanine at the penultimate position. Its catalytic triad (Ser630-Asp708-His740) facilitates this cleavage, inactivating incretin hormones such as GLP-1 and GIP, which are crucial for glucose regulation. Additionally, this enzyme breaks down proline-rich dietary proteins like gluten and casein into smaller, more digestible fragments, thereby reducing the burden of undigested peptides in the gut.
Clinical Narrative (Provisional)
Clinical research has primarily investigated DPP-IV enzyme's efficacy in breaking down proline-rich peptides, such as gluten and casein. These studies indicate its potential to mitigate symptoms associated with dietary protein sensitivities and enhance overall digestive comfort by reducing undigested peptide load. While DPP-IV's physiological role in inactivating incretins like GLP-1 and GIP is well-established, specific clinical trials evaluating DPP-IV supplementation for glucose regulation were not detailed in the provided information. Its observed benefits are predominantly linked to improved protein digestion and gut health.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.